DekaBank Deutsche Girozentrale’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-19,500
| Closed | -$292K | – | 1070 |
|
|
2016
Q2 | $292K | Buy |
19,500
+5,400
| +38% | +$80.9K | ﹤0.01% | 790 |
|
|
2016
Q1 | $173K | Sell |
14,100
-2,500
| -15% | -$30.7K | ﹤0.01% | 870 |
|
|
2015
Q4 | $263K | Buy |
16,600
+500
| +3% | +$7.92K | ﹤0.01% | 819 |
|
|
2015
Q3 | $247K | Buy |
16,100
+600
| +4% | +$9.21K | ﹤0.01% | 819 |
|
|
2015
Q2 | $377K | Buy |
15,500
+500
| +3% | +$12.2K | ﹤0.01% | 761 |
|
|
2015
Q1 | $349K | Sell |
15,000
-2,100
| -12% | -$48.9K | ﹤0.01% | 796 |
|
|
2014
Q4 | $437K | Sell |
17,100
-1,600
| -9% | -$40.9K | 0.01% | 717 |
|
|
2014
Q3 | $582K | Buy |
18,700
+400
| +2% | +$12.4K | 0.01% | 624 |
|
|
2014
Q2 | $473K | Sell |
18,300
-1,300
| -7% | -$33.6K | 0.01% | 606 |
|
|
2014
Q1 | $458K | Buy |
+19,600
| New | +$458K | 0.01% | 587 |
|